PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
May 20, 2019Journal of Clinical Oncology

PACIFIC-2: Phase 3 study of concurrent durvalumab and platinum-based chemoradiotherapy in patients with unresectable, stage III NSCLC.

View Full Paper
Ask AI
Bookmark
Share

Authors

JBJeffrey D. BradleyMNMakoto NishioIOIsamu Okamoto

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bradley et al. (2019) studied this question.

synapsesocial.com/papers/6a1d33ea5b7fddc35204f8bchttps://doi.org/10.1200/jco.2019.37.15_suppl.tps8573
View Full Paper
Ask AI
Bookmark
Share